FindTrial
Sign In

Cost-effectiveness Analysis on Pharmacotherapy for PDA Management in Preterm Newborns

Cost-effectiveness Analysis on Pharmacotherapy for PDA Management in Preterm Newborns

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022066
Enrollment
Unknown
Registered
2019-03-23
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PDA in preterm newborns

Interventions

Group 1:Using indomethacin to close ductus arteriosus
Group 2:Using ibuprofen to close ductus arteriosus
Group 3:Using acetaminophen to close ductus arteriosus

Sponsors

Children's Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Preterm newborns with PDA.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Closed ductus arteriosus;Costs;—

Countries

China

Contacts

Public ContactZhiping Li
zplifudan@126.com+86 021-64931224

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026